Agios Pharmaceuticals Inc
AGIO
Loading quote...
Financials
| 52Week High | 62.58 | 52Week Low | 23.42 |
| Beta | 0.85 | Current Ratio Annual | 11.90 |
| Current Ratio Quarterly | 14.48 | Gross Margin TTM | 88.18 |
| Market Cap | 2.15B | Net Profit Margin TTM | 1,590.42 |
| Operating Margin TTM | 1,535.42 | Price To Book | 1.57 |
| Price To Earnings TTM | 3.30 | Price To Sales TTM | 52.49 |
| Quick Ratio Annual | 11.06 | Quick Ratio Quarterly | 13.41 |
| Return On Assets TTM | 40.12 | Return On Equity TTM | 43.31 |
| Return On Investment TTM | 43.31 | Revenue Growth3Y | -27.15 |
| Revenue Growth5Y | -12.18 | Revenue Growth Quarterly Yoy | 44.57 |
| Revenue Growth TTMYoy | 30.56 | Revenue Per Share TTM | 0.71 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 227 | 2 | 3 | 4 | 5 | 0 | 60.43M | $1.83B |
| Mar 31, 2025 | 220(-3%) | 34(+1600%) | 41(+1267%) | 75(+1775%) | 75(+1400%) | 30(+%) | 60.70M(+0%) | $1.65B(-10%) |
| Jun 30, 2025 | 214(-3%) | 16(-53%) | 25(-39%) | 86(+15%) | 75 | 28(-7%) | 61.89M(+2%) | $1.91B(+16%) |